The importance of multi-hit TP53 mutations has been recently emphasized[4,5] and included in the current International Consensus Classification of Myeloid Neoplasms and Acute Leukemias[3], but the requirement for multifaceted approaches to accurately identify multi-hit mutations at the TP53 locus has been an ongoing dilemma. The gene discussed is TP53; the disease is acute leukemia.